Location History:
- Jamestown, RI (US) (2017)
- Boston, MA (US) (2013 - 2019)
Company Filing History:
7 out of 757 
6 out of 8 Years Active: 2013-2019
Title: Max Diem: Innovator in Biological Imaging and Analysis
Introduction
Max Diem is a prominent inventor based in Boston, MA, known for his significant contributions to the field of biological imaging and analysis. With a total of 11 patents to his name, Diem has developed innovative methods that enhance the diagnosis and understanding of biological specimens.
Latest Patents
Among his latest patents, Diem has created methods and systems for identifying cellular subtypes in an image of a biological specimen. This invention involves receiving a data set associated with a cohort of biological specimens and determining potential clusters within the data. By associating these clusters with data points, Diem's method allows for the identification of biologic subtypes, which can lead to new diagnostic and therapeutic insights. Another notable patent is a method for analyzing biological specimens through spectral imaging. This technique provides a medical diagnosis by obtaining spectral and visual images, enabling the detection of cell abnormalities, pre-cancerous cells, and cancerous cells. This method addresses the biases and unreliability found in traditional histopathological methods.
Career Highlights
Diem has worked with esteemed institutions such as Northeastern University and Cireca Theranostics, LLC. His work in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in medical diagnostics.
Collaborations
Diem has collaborated with notable individuals in his field, including Stanley H Remiszewski and Benjamin Bird. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of technology in biological analysis.
Conclusion
Max Diem's contributions to the field of biological imaging and analysis have made a significant impact on medical diagnostics. His innovative patents and collaborations highlight his dedication to improving the understanding of biological specimens.